Pathological results in patients eligible for six international active surveillance protocols

被引：0
|
作者：
El Hajj, A. [1 ]
Ploussard, G. [1 ]
Radulescu, C. [2 ]
Defourmestraux, A. [1 ]
Gillion, N. [1 ]
Vordos, D. [1 ]
Hoznek, A. [1 ]
Yiou, R. [1 ]
Allory, Y. [2 ]
De La Taille, A. [1 ]
Abbou, C. C. [1 ]
Salomon, L. [1 ]
机构：
[1] CHU Mondor, Dept Urol, Creteil, France
[2] CHU Mondor, Dept Pathol, Creteil, France
来源：
EUROPEAN UROLOGY SUPPLEMENTS | 2012年 / 11卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E757 / U608
页数：2
相关论文
共 50 条
  • [41] First results from the international active surveillance study on oral contraception
    Dinger, Juergen C.
    Heinemann, Lothar A. J.
    Westhoff, Carolyn
    OBSTETRICS AND GYNECOLOGY, 2007, 109 (04): : 58S - 59S
  • [42] Indications for intervention during active surveillance of prostate cancer: a comparison of the Johns Hopkins and Prostate Cancer Research International Active Surveillance (PRIAS) protocols
    Kates, Max
    Tosoian, Jeffrey J.
    Trock, Bruce J.
    Feng, Zhaoyong
    Carter, H. Ballentine
    Partin, Alan W.
    BJU INTERNATIONAL, 2015, 115 (02) : 216 - 222
  • [43] Predictive factors of unfavorable prostate cancer in patients who underwent prostatectomy but eligible for active surveillance
    Choo, Seol Ho
    Jeon, Hwang Gyun
    Jeong, Byong Chang
    Seo, Seong Il
    Jeon, Seong Soo
    Choi, Han Yong
    Lee, Hyun Moo
    PROSTATE INTERNATIONAL, 2014, 2 (02) : 70 - 75
  • [44] Clinical characteristics and pathologic findings in patients eligible for active surveillance who underwent radical prostatectomy
    Drouin, Sarah J.
    Comperat, Eva
    Cussenot, Olivier
    Bitker, Marc-Olivier
    Haertig, Alain
    Roupret, Morgan
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2012, 30 (04) : 402 - 407
  • [45] High Risk of Under-Grading and -Staging in Prostate Cancer Patients Eligible for Active Surveillance
    Heidegger, Isabel
    Skradski, Viktor
    Steiner, Eberhard
    Klocker, Helmut
    Pichler, Renate
    Pircher, Andreas
    Horninger, Wolfgang
    Bektic, Jasmin
    PLOS ONE, 2015, 10 (02):
  • [46] Comparative rates of upstaging and upgrading in Caucasian and Korean prostate cancer patients eligible for active surveillance
    Jeon, Hwang Gyun
    Yoo, Jae Ho
    Jeong, Byong Chang
    Seo, Seong Il
    Jeon, Seong Soo
    Choi, Han-Yong
    Lee, Hyun Moo
    Ferrari, Michelle
    Brooks, James D.
    Chung, Benjamin I.
    PLOS ONE, 2017, 12 (11):
  • [47] THE RATE OF ADVERSE DISEASE AND BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY IN PATIENTS ELIGIBLE FOR ACTIVE SURVEILLANCE
    Schmitges, Jan
    Heinzer, Hans
    Budaeus, Lars
    Tennstedt, Pierre
    Hansen, Jens
    Quoc-Dien Trinh
    Schlomm, Thorsten
    Steuber, Thomas
    Salomon, Georg
    Weissbach, Lothar
    Huland, Hartwig
    Graefen, Markus
    Chun, Felix K.
    JOURNAL OF UROLOGY, 2012, 187 (04): : E403 - E403
  • [48] COMPARATIVE ANALYSIS OF IMMEDIATE VERSUS DELAYED PROSTATECTOMY IN PROSTATE CANCER PATIENTS ELIGIBLE FOR ACTIVE SURVEILLANCE
    Mallya, Ashwin
    Karthikeyan, Vilvapathy Senguttuvan
    Sivaraman, Arjun
    Sanchez-Salas, Rafael
    Galiano, Marc
    Rozet, Francois
    Barret, Eric
    Cathelineau, Xavier
    JOURNAL OF UROLOGY, 2016, 195 (04): : E56 - E56
  • [49] Can Contemporary Patients with Biopsy Gleason Score 3+4 Be Eligible for Active Surveillance?
    Kwon, Ohseong
    Kim, Tae Jin
    Lee, In Jae
    Byun, Seok-Soo
    Lee, Sang Eun
    Hong, Sung Kyu
    PLOS ONE, 2014, 9 (09):
  • [50] The pathological upgrading after radical prostatectomy in low-risk prostate cancer patients who are eligible for active surveillance: How safe is it to depend on bioptic pathology?
    Verep, Samed
    Erdem, Selcuk
    Ozluk, Yasemin
    Kilicaslan, Isin
    Sanli, Oner
    Ozcan, Faruk
    PROSTATE, 2019, 79 (13): : 1523 - 1529
12345